UNICA IRIS Institutional Research Information System

PUZZONI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 58.765
NA - Nord America 2.682
AS - Asia 1.205
SA - Sud America 225
AF - Africa 30
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 62.911
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 58.069
US - Stati Uniti d'America 2.618
SG - Singapore 502
CN - Cina 428
SE - Svezia 199
BR - Brasile 186
DE - Germania 114
VN - Vietnam 96
GB - Regno Unito 64
UA - Ucraina 64
FI - Finlandia 62
FR - Francia 54
IN - India 43
CA - Canada 38
NL - Olanda 36
HK - Hong Kong 31
KR - Corea 24
MX - Messico 19
PL - Polonia 19
AT - Austria 18
ES - Italia 16
JP - Giappone 14
AR - Argentina 13
EC - Ecuador 11
IE - Irlanda 10
ZA - Sudafrica 10
BE - Belgio 8
RU - Federazione Russa 8
TR - Turchia 8
MA - Marocco 7
ID - Indonesia 6
IR - Iran 6
KG - Kirghizistan 6
PK - Pakistan 6
VE - Venezuela 6
TH - Thailandia 5
BD - Bangladesh 4
CO - Colombia 4
IQ - Iraq 4
PH - Filippine 4
TN - Tunisia 4
AU - Australia 3
GR - Grecia 3
IL - Israele 3
LV - Lettonia 3
PE - Perù 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
KE - Kenya 2
LU - Lussemburgo 2
NG - Nigeria 2
PT - Portogallo 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NO - Norvegia 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 62.911
Salva come PNG Salva come JPEG
Città #
Cagliari 56.216
Uta 1.551
Ashburn 338
Dallas 286
Fairfield 245
Singapore 237
Boardman 144
Woodbridge 133
Nyköping 129
Houston 125
Chandler 111
Seattle 111
Beijing 108
Cambridge 87
Wilmington 77
Dearborn 69
Los Angeles 66
New York 58
Santa Clara 55
Ann Arbor 51
Rome 39
Helsinki 38
Boston 37
Shanghai 37
Jacksonville 30
Dong Ket 28
Hong Kong 28
Ho Chi Minh City 26
Hefei 25
Munich 25
Buffalo 23
Seoul 23
Nanjing 20
Amsterdam 19
Redondo Beach 19
Chicago 18
Frankfurt am Main 18
London 18
São Paulo 18
Nuremberg 17
San Diego 17
The Dalles 16
Toronto 16
Warsaw 15
Milan 14
Hanoi 13
Pune 13
Shenyang 13
Düsseldorf 12
Guangzhou 12
Turku 12
Paris 11
Poplar 10
Zhengzhou 10
Montreal 9
Vienna 9
Atlanta 8
Chennai 8
Hangzhou 8
Mont-saint-hilaire 8
Phoenix 8
Stockholm 8
Brooklyn 7
Jiaxing 7
Naples 7
Rio de Janeiro 7
Tokyo 7
Wuhan 7
Bishkek 6
Biên Hòa 6
Buenos Aires 6
Casablanca 6
Dublin 6
Johannesburg 6
Nanchang 6
Redwood City 6
Salt Lake City 6
Selargius 6
Shenzhen 6
Tianjin 6
Augusta 5
Bexley 5
Boulder 5
Centro 5
Charlotte 5
Hebei 5
Menlo Park 5
Norwalk 5
Olbia 5
Portsmouth 5
Belo Horizonte 4
Breda 4
Brussels 4
Changsha 4
Denver 4
Fortaleza 4
Guayaquil 4
Hải Dương 4
Jinan 4
La Maddalena 4
Totale 61.157
Salva come PNG Salva come JPEG
Nome #
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 4.138
Clustered protocadherins methylation alterations in cancer 3.272
BRAF-mutant colorectal cancer, a different breed evolving 3.207
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 2.939
Molecular-biology-driven treatment for metastatic colorectal cancer 2.710
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples 2.633
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.584
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.400
Colorectal cancer early detection in stool samples tracing CPG islands methylation alterations affecting gene expression 2.322
Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis 2.296
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab 2.119
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 2.093
The immune revolution in gastrointestinal tumours: leading the way or just following? 1.945
Critical features and challenges associated with imaging in patients undergoing cancer immunotherapy 1.648
Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials 1.571
Immunotherapy and Cancer: The Multi-Omics Perspective 1.552
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.488
Tumor infiltrating lymphocytes in gastrointestinal tumors: Controversies and future clinical implications 1.386
The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors 1.325
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.304
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial 1.263
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option? 1.262
Immunotherapy for colorectal cancer: where are we heading? 1.247
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.179
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 1.075
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 997
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review 982
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 937
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial 936
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 899
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 740
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 704
Uncovering key targets of success for immunotherapy in pancreatic cancer 676
Cholangiocarcinoma: new perspectives for new horizons 671
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 658
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 523
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study 468
Patients with early-onset metastatic colorectal cancer as an emerging distinctive clinical and molecular phenomenon 402
Selection with a molecUlar PanEl foR Panitumumab EfficAcy in K-RAS and N-RAS wild type metastatic colorectal cancer (SUPER-PEAK) 338
CD44: A New Prognostic Marker in Colorectal Cancer? 203
REINVENT (REgorafenIb traNslational eValuation angiogENesis proTocol) 192
A new prognostic score for biliary tract cancer: a multicenter experience 189
Clinical Outcome of Patients With Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment 180
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 169
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 149
Fentanyl pectin nasal spray for breakthrough cancer pain treatment: a single center experience 145
Medical management of malignant bowel obstruction: our center experience 145
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 144
LONG-TERM RESPONSE TO SUNITINIB, EVEROLIMUS AND AXITINIB SEQUENTIALLY USED IN A YOUNG WOMEN WITH MRCC. A CASE REPORT 126
Navigating the Landscape of Liquid Biopsy in Colorectal Cancer: Current Insights and Future Directions 114
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer 63
Influence of levothyroxine concomitant treatment on treatment responses and outcomes in patients with metastatic colorectal adenocarcinoma 63
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 53
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 49
Early onset metastatic colorectal cancer: Clinical-prognostic characteristics and correlation to molecular profile 48
The correlation between L1CAM expression and outcomes in patients with metastatic colorectal cancer treated with first-line chemotherapy 47
Comparison between different therapeutic sequences in patients affected by metastatic pancreatic ductal adenocarcinoma 46
Preoperatory FLOT Regimen for Gastroesophageal Cancer and Renal Function: A New Onco-Nephrological Perspective 46
Clinical and molecular features of early-onset metastatic pancreatic cancer and their impact on therapeutic sequences: A multicenter study 42
Totale 63.102
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.495
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.168 0 0 0 0 0 1.789 755 962 439 923 794 506
2021/20223.263 341 193 156 245 212 210 192 221 297 365 335 496
2022/20235.508 509 934 730 402 390 440 230 413 343 500 378 239
2023/20247.333 338 205 187 345 509 854 854 2.301 271 372 562 535
2024/202514.465 4.177 4.456 1.416 1.341 691 965 752 66 159 132 110 200
2025/20261.985 382 281 470 432 376 44 0 0 0 0 0 0
Totale 63.102